default author photo

Do Young Kim

Yonsei University - Department of Internal Medicine

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

1

DOWNLOADS

61

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study

Number of pages: 25 Posted: 26 Nov 2021
Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do Young Kim, Sung Kyu Hwang, Young Eun Chon and Hong Jae Chon
Yonsei University - Department of Internal Medicine, CHA University - Department of Medical Oncology, University of Ulsan - Department of Internal Medicine, CHA University - Department of Medical Oncology, CHA University - Department of Gastroenterology, Yonsei University - Department of Internal Medicine, CHA University - Department of Gastroenterology, CHA University - CHA Bundang Medical Center and CHA University - Department of Medical Oncology
Downloads 61 (951,658)
Citation 1

Abstract:

Loading...